Rapport Therapeutics Inc. Common Stock

RAPP | NASDAQ

Price Alert Chart Builder DCF Calculator

$38.29

-$1.37 (-3.45%)

Sep 22, 2026, 11:07 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Pro Subscription

Upgrade now for unlimited access to all data, tools and no ads.

Upgrade now ➞

Related Stocks

Company	Yield
ANAB AnaptysBio	N/A
BBOT BridgeBio Oncology Therapeutics	N/A
KOD Kodiak Sciences	N/A
NRIX Nurix Therapeutics	N/A
OCS Oculis	N/A
PHAT Phathom Pharmaceuticals	N/A
SEPN Septerna Inc	N/A
URGN UroGen Pharma	N/A
XNCR Xencor	N/A

Dividend Rankings ➞

Recent News

6 days ago / benzinga.com
Rapport Therapeutics To Rally Around 76%? Here Are 10 Top Analyst Forecasts For Wednesday
20 days ago / globenewswire.com
Rapport Therapeutics to Participate in Upcoming Investor Conferences
2 months ago / globenewswire.com
Rapport Therapeutics Reports Second Quarter 2026 Financials and Provides Business Update
2 months ago / fool.com
What Does the Sale of Rapport Therapeutics Stock Worth Over $400,000 by the Chief Operating Officer Mean for Investors?
4 months ago / seekingalpha.com
Rapport Therapeutics, Inc. (RAPP) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
5 months ago / zacks.com
Rapport Therapeutics, Inc. (RAPP) Reports Q1 Loss
5 months ago / globenewswire.com
Rapport Therapeutics Reports First Quarter 2026 Financials and Provides Business Update
5 months ago / globenewswire.com
Modalités de mise à disposition du rapport financier annuel 2025
5 months ago / globenewswire.com
MISE A DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025
5 months ago / globenewswire.com
Rapport Therapeutics Presents RAP-219 Focal Onset Seizure Phase 2a Follow-up Period Results Demonstrating Sustained Seizure Reduction at the 2026 American Academy of Neurology Annual Meeting